Altimmune, Inc. (ALT)

5.555 +0.16 (+3.06%) USD  |  NASDAQ  |  Jan 23, 14:03
More

Altimmune Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Seres Therapeutics, Inc. Upgrade